In the last trading session, 3.65 million NLS Pharmaceutics Ltd (NASDAQ:NLSP) shares changed hands as the company’s beta touched -0.52. With the company’s per share price at $2.69 changed hands at -$0.34 or -11.22% during last session, the market valuation stood at $6.65M. NLSP’s last price was a discount, traded about -804.83% off its 52-week high of $24.34. The share price had its 52-week low at $3.00, which suggests the last value was -11.52% down since then. When we look at NLS Pharmaceutics Ltd’s average trading volume, we note the 10-day average is 47300.0 shares, with the 3-month average coming to 215.82K.
Analysts gave the NLS Pharmaceutics Ltd (NLSP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NLSP as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. NLS Pharmaceutics Ltd’s EPS for the current quarter is expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Instantly NLSP was in red as seen at the end of in last trading. With action -24.44%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -88.60%, with the 5-day performance at -24.44% in the red. However, in the 30-day time frame, NLS Pharmaceutics Ltd (NASDAQ:NLSP) is -25.28% down. Looking at the short shares, we see there were 55986.0 shares sold at short interest cover period of 0.11 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 7.15%.
NLSP Dividends
NLS Pharmaceutics Ltd is expected to release its next quarterly earnings report in January.
ARMISTICE CAPITAL, LLC holds the second largest percentage of outstanding shares, with 6.0535% or 2.31 million shares worth $0.5 million as of 2024-06-30.
